Featured Content
The Center for Life Science Ventures was founded in 2008 as a startup incubator to help develop young Cornell life science companies. The Center is funded through the Office of the Vice President for Research and Innovation, the Institute of Biotechnology and NYSTAR.
The Center’s program focuses on accelerating research and development of its client’s companies’ technology and products, validating its client companies’ business plans, and strengthening their management teams. The Center’s goal is to facilitate the forward progress of client companies to the point where each will merit significant outside investment, and achieve self-sufficiency. In doing so, the Center for Life Science Ventures contributes to the University’s mission as New York State’s Morrill Land Grant institution to support local, regional, and state-wide Life Sciences jobs/economic development.
News
Center Graduate Kanvas Biosciences Secures Additional $12.5M to Advance Its Novel, Microbiome-Based Immuno-oncology Drug Candidates to IND Filing
July 09, 2024
https://www.prnewswire.com/news-releases/kanvas-biosciences-secures-additional-12-5m-to-advance-its-novel-microbiome-based-immuno-oncology-drug-candidates-to-ind-filing-302184016.html With $29.5 million in total funding, the company has developed the world’s leading spatial biology platform, designed for breakthroughs in drug development, clinical diagnostics, agriculture, and food safety. This proprietary mapping technology will first be used …
Startup aiming to reduce plastic reliance joins Cornell incubator
June 10, 2024
By Blaine Friedlander, Cornell Chronicle A company that originated in Syracuse and is aiming to use agricultural waste to replace the petroleum-based plastic liners in coffee cups, takeout containers and other consumer products has joined Cornell’s Center …
Center Graduate Kanvas Biosciences Announces $12 Million Pre-Series A to Accelerate Microbiome Drug Development
June 23, 2023
https://www.prnewswire.com/news-releases/kanvas-biosciences-announces-12-million-pre-series-a-to-accelerate-microbiome-drug-development-301857507.html?tc=eml_cleartime R&D breakthrough for microbiome-associated therapies: Technology brings breakthrough resolution and context to host-microbiome interactions PRINCETON, N.J., June 22, 2023 /PRNewswire/ — Kanvas Biosciences, the leader in microbiome mapping technology, announced today a $12M Pre-Series A funding round. The …
Turning toilets into health monitors, startup joins life science business incubator
June 14, 2023
By J. Edward Anthony CareTech Human, a startup developing a device to monitor urological symptoms at home, is joining Cornell’s Center for Life Science Ventures business incubator. Many patients are accustomed to the benefits and …